KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Organon (OGN) Long-Term Investments (2024)

Organon has reported Long-Term Investments over the past 1 years, most recently at $27.0 million for Q4 2024.

For Q4 2024, Long-Term Investments changed N/A year-over-year to $27.0 million; the TTM value through Dec 2024 reached $27.0 million, changed N/A, while the annual FY2024 figure was $27.0 million, N/A changed from the prior year.
Long-Term Investments for Q4 2024 was $27.0 million at Organon.
Over five years, Long-Term Investments peaked at $27.0 million in Q4 2024 and troughed at $27.0 million in Q4 2024.